User menu

Randomized Controlled Phase 2 Study (RCT) with Tivantinib in pre-treated hepatocellular carcinoma(HCC): Efficacy, Safety, and MET-analysis

Bibliographic reference Borbath, Ivan ; et. al. Randomized Controlled Phase 2 Study (RCT) with Tivantinib in pre-treated hepatocellular carcinoma(HCC): Efficacy, Safety, and MET-analysis.The Liver meeting ((United States) Boston, MA, du 09/11/2012 au 13/11/2012). In: Hepatology, Vol. 56, no. S1, p. 67A (Octobre 2012)
Permanent URL http://hdl.handle.net/2078/121585